Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

US Patent 11926676 · Granted Mar 12, 2024

Estimated economic value: $81,379,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Gene-edited natural killer cells2025
Genetically engineered T cells having improved persistence in culture2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
Circular RNA encoding chimeric antigen receptors targeting BCMA2025
Methods and compositions for treating cancer2025
Activatable anti-VEGF scFv2025
Anti-PTK7 immune cell cancer therapy2024